5 High-Yield Dividend Stocks That Could Hold Up When the Market Falls
Drugs, software, cereal, and electricity keep selling when the economy stalls. Five dividend payers pass a coverage test, but one carries a payout stretched thin and another faces a regulatory hearing that could change its income story.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Defensive income gets valuable when growth gets shaky, and this month’s list sticks to businesses people pay for in any economy: prescription drugs, enterprise software, breakfast cereal, and electricity. The shared hook is coverage. Each name below pays a dividend that earnings or free cash flow can support, and the group’s top yielder, General Mills (NYSE:GIS | GIS Price Prediction), now pays a forward yield of 6.74% after the stock fell 16.84% year to date. Every pick prioritizes safety. Yield comes second.
Johnson & Johnson: A Dividend King Guiding Past $100 Billion
Johnson & Johnson (NYSE:JNJ) pays $1.34 per quarter, or $5.36 annualized, for a forward yield of 1.95% at a share price near $274.54. That is the lowest yield on this list, and it reflects a stock that has gained 34.8% this year. J&J earns its spot on safety.
Dividend safety: The board raised the payout 3.1% in April 2026, which the company marked as its 64th consecutive year of increases (a streak that puts it in rare company, the same 50-plus-year club we ranked by valuation in a free Dividend Kings report). The payment history backs that up, with the quarterly rate climbing every year from $0.90 in 2019 to today’s $1.34. Against the midpoint of 2026 adjusted EPS guidance of $11.60 to $11.75, the annual dividend uses roughly 46% of earnings, leaving plenty of room for raise number 65.
Bull case: Second-quarter revenue rose 6.6% to $25.31 billion, and adjusted EPS of $2.90 exceeded the $2.8545 estimate. TREMFYA sales jumped 72.5%, and DARZALEX grew 18.9%. In July, the company raised full-year revenue guidance to $100.8 billion to $101.4 billion, and the CEO said it was “on track to meet our 2026 target of more than $100 billion in annual revenue for the first time in our Company’s 140-year history.” Investors should check that outlook against the latest quarterly update.
Risk: STELARA sales fell 55.2% as biosimilars arrived, talc litigation produced $267 million in second-quarter charges, and the planned Orthopedics separation adds execution risk.
IBM: Free Cash Flow Is Climbing Behind a Century-Old Dividend
IBM (NYSE:IBM) pays $1.69 per quarter, or $6.76 annualized, for a forward yield of 2.71%. The next ex-dividend date is November 10, 2026.
Dividend safety: IBM has paid quarterly dividends every year since 1916, and its record shows small annual increases, from $1.67 in 2025 to $1.69 now. Third-quarter free cash flow rose 22.2% to $3.03 billion, and operating cash flow climbed 30.6% to $4.03 billion. The quarterly dividend equals about 57% of the quarter’s $2.95 adjusted EPS.
Bull case: Revenue grew 4.7% to $17.10 billion, beating the $16.84 billion estimate, as Software rose 8% with Red Hat up 11%. Management raised its 2026 free cash flow outlook to an increase of more than $1 billion year over year. Shares are down 13.94% year to date even as cash generation improves, which lifts the yield.
Risk: Total debt is $63.8 billion, mainframe sales are cyclical (IBM Z fell 42% in the second quarter), and a securities fraud inquiry into pipeline disclosures is pending.
Pfizer: A 5.66% Yield With Guidance Moving Higher
Pfizer (NYSE:PFE) pays $0.43 per quarter, or $1.72 a year, for a 5.66% yield at roughly $30.42. That makes it a high-yield name, just shy of ultra-high territory. The stock goes ex-dividend on November 6, 2026.
Dividend safety: Coverage looks better than the yield suggests. The $2.95 to $3.05 adjusted EPS guidance puts the payout at about 57% of earnings at the midpoint. Leverage is manageable, with net debt to EBITDA of 2.76 and interest coverage of 6.52. Pfizer has also skipped buybacks in 2026, steering cash toward the dividend and de-levering. The quarterly rate has edged up from $0.38 in 2020 to $0.43, though it has held flat since early 2025.
Bull case: Third-quarter adjusted EPS of $0.87 beat the $0.73 estimate for a 7th straight beat, and full-year revenue guidance rose to $62.0 to $64.0 billion. The non-COVID portfolio grew 7% operationally, led by Eliquis, up 25%, and Padcev, up 55%. At a P/E of 23, obesity and oncology pipeline wins would come as upside.
Risk: Free cash flow yield of 5.17% trails the dividend yield, Paxlovid sales dropped 63%, and guidance includes a roughly $1.1 billion hit from generic and biosimilar competition.
General Mills: An Ultra-High Yield From a 127-Year Payer
General Mills pays $0.61 per quarter, or $2.44 annually, for a hefty forward yield of 6.74%.
Dividend safety: The July declaration marked the company’s 127th consecutive year of continuous dividends. Against fiscal 2027 adjusted EPS guidance of $3.00 to $3.20, the payout runs about 79% of earnings at the midpoint. That is tighter than the pharma names, but management expects free cash flow conversion of about 95% of adjusted after-tax earnings, and buybacks were cut to $500 million in fiscal 2026 from $1.2 billion, leaving cash for the dividend.
Bull case: Second-quarter adjusted EPS of $0.75 beat the $0.72 estimate, and guidance was reaffirmed. The company is aiming for $3 billion in cumulative cost savings by fiscal 2030. Buyers are already lining up: shares rose 9.5% over the past week.
Risk: Fiscal 2026 free cash flow fell 29% to $1.63 billion, organic sales guidance ranges from -1.5% to +0.5%, and a $1.75 billion impairment on North America Pet shows how much pressure the portfolio is under. The quarterly rate has held at $0.61 since mid-2025.
Dominion Energy: Data-Center Demand Powers a 3.85% Yield
Dominion Energy (NYSE:D) pays $0.6675 per quarter, or $2.67 annually, for a forward yield of 3.85%. The company declared the latest payment on October 27, 2026.
Dividend safety: Dominion cut its quarterly payout from $0.94 to $0.63 in late 2020 and has held it at $0.6675 since 2022. That reset now works in shareholders’ favor. The dividend uses about 75% of the midpoint of 2026 operating EPS guidance of $3.45 to $3.69, a normal level for a regulated utility, and management expects to land in the top half of that range. The company reaffirmed its dividend and credit guidance in the third-quarter release.
Bull case: Third-quarter revenue rose 24.1% to $5.62 billion, and operating EPS of $1.28 beat estimates for the 7th straight quarter. Dominion Energy Virginia’s operating earnings rose to $862 million from $679 million, boosted by rate outcomes and surging data-center load in Loudoun County. The utility serves 3.6 million homes and businesses, a customer base that keeps paying through recessions.
Risk: The pending merger faces a Virginia evidentiary hearing in November 2026, offshore wind costs produced $95 million in unrecoverable charges year to date, and diluted shares rose to 882.1 million from 855.4 million.
Five Payers Built to Hold Up When the Economy Slows
The list runs from J&J’s growth-backed payout to General Mills’ 6.74% yield, and every dividend here is supported by earnings guidance or rising cash flow. Pfizer and IBM add yield as earnings rise, and Dominion pairs a regulated customer base with surging data-center demand. General Mills’ free cash flow and Dominion’s merger hearing deserve close attention. Those two items are most likely to move this group’s dividend outlook in the months ahead.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
